Back to News
research

Allegro MicroSystems: Why It's Time To Take Profits

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Analyst Andrea De Vico assigns a "Sell" rating to the semiconductor firm, citing a 106% overvaluation with shares trading at $44 against a $20.98 fair value estimate. Market pricing assumes a 30-35% five-year revenue CAGR, an unsustainable rate given the company’s historical 5-10% growth and peer benchmarks. While the firm shows genuine recovery post-2024-25 downturns, structural risks persist, including margin compression and rigid operations during cyclical declines. Investors are urged to exit positions after recent gains, as current valuations lack support from tangible fundamentals or sector-wide tailwinds. De Vico’s analysis relies on quantitative models, stressing the gap between speculative pricing and realistic growth trajectories in the semiconductor space.
AI Audio Summary
0:00 / 0:00
Click to play
Allegro MicroSystems: Why It's Time To Take Profits

Summarize this article with:

Andrea De Vico58 FollowersFollow5ShareSavePlay(18min)CommentsFollow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock newsSummaryAllegro MicroSystems is rated Sell due to significant overvaluation, with a fair value of $20.98 versus a current price near $44.Current market pricing implies an implausible 30-35% revenue CAGR over five years, unsupported by historical or peer growth rates.ALGM's recent recovery is real, but margin compression and operational inflexibility during downturns highlight structural risks.Investors are advised to cash out after the stock's run-up and await tangible fundamental drivers before reconsidering ALGM.sankai/E+ via Getty Images Investment Thesis I value Allegro MicroSystems (ALGM) with a Sell rating. The company is undergoing a good recovery process after the bad business years in FY2024 and FY2025, and I expect this recovery to gradually persist inThis article was written byAndrea De Vico58 FollowersFollowI am a finance professional in training with a strong focus on equity research and financial analysis. Currently pursuing a quantitative Master’s degree in Economics and Finance, I apply a rigorous and fundamentals-driven approach complemented by statistical and stochastic methods to evaluate companies and industries. My research interests span multiple sectors, including semiconductors, healthcare and biotechnology, financial services and industrials. I aim to deliver deep and high-conviction analyses grounded in transparent and testable assumptions, where every conclusion is supported by a clear, structured, and evidence-based methodology.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read Original

Source Information

Source: Seeking Alpha